Jian-wen Xiong
Biographic Data
| ID | 10422782 |
|---|---|
| NAME | Jian-wen Xiong |
| GIVEN NAMES | Jian-wen |
| FAMILY NAME | Xiong |
| SIGNATURE | XIONG J |
| AFFILIATIONS | Nanchang University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Changes in plasma hydrogen sulfide are associated with cognitive improvements in schizophrenia patients treated with atypical antipsychotics
Background Hydrogen sulfide (H2S) acts as a neuromodulator in the brain and is shown to be associated with cognitive impairments in schizophrenia. Atypical antipsychotics can provide cognitive benefits for schizophrenia patients. This prospective observational study aims to investigate whether H 2 S signaling is involved in the cognitive improvement effects of atypical antipsychotics in patients with schizophrenia. Methods A total of 25 schizophr…
Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia
Schizophrenia is linked with abnormal neurodevelopment, on which growth differentiation factor 11 (GDF-11) has a great impact. However, a direct evidence linking GDF-11 to the pathophysiology of schizophrenia is still lacking. The current study aimed to investigate the relationship between plasma GDF-11 levels and both psychopathological symptoms and cognitive function in schizophrenia. Eighty-seven schizophrenia patients and 76 healthy controls …
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
Cognitive deficits represent a core feature of schizophrenia. Previous studies have demonstrated that plasma asymmetric dimethylarginine (ADMA) was increased in patients with schizophrenia and correlated with cognitive impairments. Atypical antipsychotics can produce cognitive benefits in schizophrenia patients. In this study, we conducted a prospective observation trial to explore whether plasma ADMA may serve as an indicator for evaluating cogn…
No prominent works on this page.
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
Cognitive deficits represent a core feature of schizophrenia. Previous studies have demonstrated that plasma asymmetric dimethylarginine (ADMA) was increased in patients with schizophrenia and correlated with cognitive impairments. Atypical antipsychotics can produce cognitive benefits in schizophrenia patients. In this study, we conducted a prospective observation trial to explore whether plasma ADMA may serve as an indicator for evaluating cogn…
Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia
Schizophrenia is linked with abnormal neurodevelopment, on which growth differentiation factor 11 (GDF-11) has a great impact. However, a direct evidence linking GDF-11 to the pathophysiology of schizophrenia is still lacking. The current study aimed to investigate the relationship between plasma GDF-11 levels and both psychopathological symptoms and cognitive function in schizophrenia. Eighty-seven schizophrenia patients and 76 healthy controls …
Changes in plasma hydrogen sulfide are associated with cognitive improvements in schizophrenia patients treated with atypical antipsychotics
Background Hydrogen sulfide (H2S) acts as a neuromodulator in the brain and is shown to be associated with cognitive impairments in schizophrenia. Atypical antipsychotics can provide cognitive benefits for schizophrenia patients. This prospective observational study aims to investigate whether H 2 S signaling is involved in the cognitive improvement effects of atypical antipsychotics in patients with schizophrenia. Methods A total of 25 schizophr…
Cognition (3 works) · Schizophrenia (object-oriented programming (3 works) · Antipsychotic (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Neuropsychology (2 works) · Positive and Negative Syndrome Scale (2 works) · Psychiatry (2 works)